Trump announces University of Miami gifted 1994 Ibogaine IND application to U.S. government
President Donald J. Trump announced that Secretary Kennedy has received a "Historic Gift" from the University of Miami: its original 1994 Ibogaine Investigational New Drug (IND) application. This aims to provide direct access to foundational FDA authorization to accelerate Ibogaine's development as a medical treatment in the U.S. for serious mental illness, building on an Executive Order Trump signed in April to accelerate such treatments. Trump noted Joe Rogan was present with him and veterans in the Oval Office when discussing Ibogaine's benefits for veterans.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Oasys (OAS) Project Analysis: The Intersection of Gaming Chains and On-Chain Perpetual Contracts
-
2
Global Virtual Currency Wallet Types and the Current State of Cryptocurrency Trading Platforms in Mainland China
-
3
HAN Token Analysis: What is HanChain? How to Trade and Acquire It?
-
4
RSS3: Web3 Decentralized Information Protocol and Its Token Analysis
-
5
Crypto market enters October after strong Q3, eyes Ethereum testnet and ETF flows
-
6
ENJ Trading Guide: How to Buy and Sell Enjin Tokens and Their Listed Exchanges
-
7
YFC (Yearnchange) Token Analysis: The Current State and Risks of DeFi Copycats
-
8
Aave Official Community Channels Explained: Do WeChat Groups Exist and How to Participate Safely
-
9
An Analysis of USDC's Performance and Role During Financial Crises
-
10
BAI Token Analysis: An Overview of a Crypto Asset with Multiple Identities
Markets Today
Recommended Reading











